![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The Cost of Making Hepatitis C a Rare Disease in the United States
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Jagpreet Chhatwal1, Xiaojie Wang2, Mark S. Roberts3, Mina Kabiri3, Turgay Ayer2, Julie M. Donohue3, Fasiha Kanwal4
1Massachusetts General Hospital, Harvard Medical School, Boston, MA; 2Georgia Institute of Technology, Atlanta, GA;
3University of Pittsburgh, Pittsburgh, PA;
4Michael E. DeBakey Veterans Affairs Medical Center, and Baylor College of Medicine, Houston, TX
![AASLD1.gif](../images/120715/120715-4/AASLD1.gif)
![AASLD2.gif](../images/120715/120715-4/AASLD2.gif)
![AASLD3.gif](../images/120715/120715-4/AASLD3.gif)
![AASLD4.gif](../images/120715/120715-4/AASLD4.gif)
![AASLD5.gif](../images/120715/120715-4/AASLD5.gif)
![AASLD6.gif](../images/120715/120715-4/AASLD6.gif)
![AASLD7.gif](../images/120715/120715-4/AASLD7.gif)
![AASLD8.gif](../images/120715/120715-4/AASLD8.gif)
![AASLD9.gif](../images/120715/120715-4/AASLD9.gif)
![AASLD10.gif](../images/120715/120715-4/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|